Edwards Lifesciences Corp (EW) Financials
Key financial figures for Edwards Lifesciences Corp (Q1 2026).
- Revenue
- $1.6B
- Net Income
- $381M
- EPS
- $0.66
- Total Assets
- $13.3B
- Operating Cash Flow
- $44M
Full income statement, balance sheet, and cash flow for Edwards Lifesciences Corp on SentiSense.